© 2003 by BMJ Publishing Group & British Society of Gastroenterology
Digest
Associate Editor
| The first 150 words of the full text of this article appear below. |
A paper in this journal two years ago caused quite a stir in the media as it highlighted the alarming increase in mortality from cholangiocarcinoma in the UK. The associated rise in incidence is not explained by enhanced diagnosis—it's real. The group from St Mary's that made the earlier observation now speculate that an environmental carcinogen is to blame. They studied DNA adduct formation as a marker of DNA damage and as a primary event in chemical carcinogenesis. In cholangiocarcinomas, they found that there were more DNA adducts than in controls. Maybe this will initiate the search for the causative agent(s). Gut wishes them well in the hunt but don't bet against the epidemiologists getting there first. See 586
|
If you take the "it's not in your mind, it's in your guts" approach to explaining irritable bowel syndrome to
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
Relevant Articles
- Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents
- W H Wang, W M Wong, D Dailidiene, D E Berg, Q Gu, K C Lai, S K Lam, and B C Y Wong
Gut 2003 52: 490-495.[Abstract] [Full Text] [PDF]
- Fracture experience of patients with coeliac disease: a population based survey
- K Thomason, J West, R F A Logan, C Coupland, and G K T Holmes
Gut 2003 52: 518-522.[Abstract] [Full Text] [PDF]
- Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study
- M Wright, R Goldin, A Fabre, J Lloyd, H Thomas, C Trepo, P Pradat, and M Thursz
Gut 2003 52: 574-579.[Abstract] [Full Text] [PDF]
- DNA adducts, detected by 32P postlabelling, in human cholangiocarcinoma
- S A Khan, P L Carmichael, S D Taylor-Robinson, N Habib, and H C Thomas
Gut 2003 52: 586-591.[Abstract] [Full Text] [PDF]
- Antidepressants for irritable bowel syndrome
- R E Clouse
Gut 2003 52: 598-599.[Extract] [Full Text] [PDF]
- Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors
- C J Hawkey and M J S Langman
Gut 2003 52: 600-608.[Abstract] [Full Text] [PDF]
Services
- Email this link to a friend
- Similar articles in this journal
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
